ArticleBritish journal of haematology2019

The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.

Gordon Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.